BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 1, 2017
View Archived Issues
Novel Drosophila FXS model as promising screening strategy for therapeutic discovery
Read More
EpimAb Biotherapeutics and WuXi Biologics collaborate to advance development of EMB-01
Read More
Advaxis and BMS to test ADXS-DUAL plus Opdivo in metastatic cervical cancer
Read More
Sylentis initiates phase III HELIX study of SYL-1001as treatment of dry eye syndrome
Read More
Researchers design a novel antibody-powered DNA-based nanomachine
Read More
ProQR Therapeutics receives FDA fast track designation for QR-110
Read More
EMA's COMP recommends orphan medicinal product designation for Catalyst Biosciences' CB-2679d
Read More
Alnylam's givosiran receives FDA breakthrough therapy designation
Read More
IMIDomics enters strategic collaboration with Celgene
Read More
Eisai and Johns Hopkins announce extension of their drug discovery collaboration
Read More
Phase III HALO study of fremanezumab in migraine meets endpoints
Read More
FDA grants rare pediatric disease designation to Amicus' SD-101 for epidermolysis bullosa
Read More
New model reveals role of IRAK-M in rhinovirus infection
Read More
AstraZeneca presents serine-protein kinase ATM inhibitors
Read More
FDA grants priority review to Vyxeos NDA for AML
Read More
FDA approves Novo Nordisk's Rebinyn for hemophilia B
Read More
Roche divulges equilibrative nucleoside transporter 1 inhibitors
Read More
MabVax enters research agreement with Memorial Sloan Kettering for CAR T-cell therapeutics
Read More
Simon Fraser University and collaborator discover MRSA pyruvate kinase inhibitors
Read More
FDA approves first topical ocular formulation of cetirizine
Read More
R-Pharm CJSC presents MEK1/2 inhibitors
Read More
Phase III study of elafibranor in NASH recommended to continue by DSMB
Read More
Servier and ILTOO Pharma enter license agreement for ILT-101
Read More
Janssen Pharmaceutica discloses PDE2 inhibitors
Read More
FDA, EMA accept Pfizer's applications seeking to expand approved use of Sutent
Read More
Review committee recommends dose escalation in MEI Pharma's phase I study of ME-401
Read More
Minerva Neurosciences to amend MIN-202 agreement with Janssen
Read More
First patient enters Oncology Venture's phase I/II study of APO-010
Read More
Transient improvement seen in children with autism treated with suramin
Read More
FAM46A mutations found to cause a form of osteogenesis imperfecta
Read More